Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Safety Cohort Study VLA1553-406

NCT07254702 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.

NCT NCT07254702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07254702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Safety Cohort Study VLA1553-406
Lead sponsor
Valneva Austria GmbH
Phase
Observational
Overall status
Active, not recruiting
Start date
February 2, 2026
Completion date
February 28, 2027
Enrollment
5,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chikungunya virus infection